ELB-139 is a GABA A receptor agonist potentially for the treatment of anxiety and panic disorder. ELB139 increases 5-HT in the striatum and prefrontal cortex a microdialysis study. References: Landmark CJ, Johannessen SI. Modifications of antiepileptic drugs for improved tolerability and efficacy. Perspect Medicin Chem. 2008 Feb 14;2:21-39. PubMed PMID: 19787095; PubMed Central PMCID: PMC2746576.

纯度：≥98%

CAS：188116-08-7